Cancer surgery antibiotics: a hidden gut microbe mystery
NCT ID NCT04875728
Summary
This study aims to understand how a common antibiotic given right before surgery affects the community of bacteria in the gut (the microbiome) of patients with early-stage skin cancer (melanoma). Researchers will compare patients who receive the antibiotic to those who do not, checking their gut bacteria and immune system before and after surgery. The goal is to learn if these changes influence how the body heals and responds to cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL STAGE I CUTANEOUS MELANOMA AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.